Status:
UNKNOWN
Intratympanic Stereoidal Injections for Facial Nerve Palsy
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Bell Palsy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Bell's palsy is defined as a facial nerve palsy without any other known cause. The common practice for this disease consists of the use of oral steroids. Such treatment can cause harm to people who ha...
Detailed Description
Bell's palsy is defined as a facial nerve paralysis without any other known diagnosis or cause .Its' estimated occurrence is in 20 to 30 people per 100,000 people per year. The occurence is greater in...
Eligibility Criteria
Inclusion
- Adult patients 18 years old or more, diagnosed with Bell's palsy who cannot receive oral steroid treatment for their condition, due to to pregnancy, diabetes, high blood pressure etc.
Exclusion
- Children under the age of 18.
- Patients who can receive oral steroid treatment for their condition.
- Patients with internal ear problems. \* Patients who already recieved treatmetn for their condition.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2019
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03371589
Start Date
February 1 2018
End Date
August 1 2019
Last Update
January 25 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.